Background. Vancomycin-resistant Enterococcus faecium (VRE) is a common cause of healthcare-associated infections. In 2009, VRE colonization/infection rates rose on the adult hematology-oncology wards at the NIHCC, prompting initiation of active surveillance cultures in 2009. Whereas colonization/infection rates subsequently declined, they did not return to baseline. We describe a cohort of 333 patients detected between 2007-2013 with VRE colonization or infection.
Methods. Starting in July 2009, perirectal swabs were collected on admission and weekly from non-colonized patients and plated on selective media. In July 2010, swabs were tested by VanA/VanB PCR (Cepheid)
Results. Surveillance swabs identified VRE colonization in 65%; clinical cultures identified 35%. Of 215 identified by active surveillance, 24% later grew VRE from clinical cultures.
Among the 215, 65% grew VRE in culture, and 35% had positive PCR, but negative cultures (PCR + /Cx-). Only 30% of PCR + /Cx-patients with subsequent swabs grew VRE from cultures. PCR + /Cx-swabs grew 41 organisms: vancomycin-susceptible E. faecium/faecalis (27%), vancomycin-resistant E. faecalis (5%), E. gallinarum/casseliflavus (44%), and others (24%). PCR had a positive predictive value of 43%, and 95% of identified organisms were not VRE.
Of 140 with initial positive surveillance cultures, 33% grew VRE from clinical cultures. 32% had ≥3 subsequent negative swabs, but 21% later grew VRE a median of 46 days after the last negative surveillance culture.
Overall, 19% had VRE bacteremia. 44% of all patients died, including 49% initially identified in clinical culture, 72% of those who had VRE bacteremia, 44% identified in surveillance culture and 39% who were PCR + /Cx-.
Conclusion. VRE colonization is tenacious; only 17% of our patients appeared to become decolonized. The low positive predictive value of PCR testing is likely influenced by vancomycin resistance genes in non-VRE bacteria. Mortality in patients with VRE colonization/infection is high, and colonization may be a surrogate marker for underlying disease severity. Understanding the dynamics of VRE colonization is essential for reducing its prevalence.
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